Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.

[1]  M. Anscher,et al.  Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor , 1995, Annals of surgery.

[2]  M. Sporn,et al.  Maternal rescue of transforming growth factor-beta 1 null mice. , 1994, Science.

[3]  T. Murase,et al.  Transforming growth factor-beta plasma concentrations in patients with leukemia and lymphoma receiving chemoradiotherapy and marrow transplantation [letter] , 1994 .

[4]  L. Marks,et al.  Estimation of normal tissue complication probabilities with three-dimensional technology. , 1994, International journal of radiation oncology, biology, physics.

[5]  R. Neta,et al.  Pathophysiological roles of cytokines in development, immunity, and inflammation 1 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  R W de Boer,et al.  A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  T G Turkington,et al.  The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. , 1993, International journal of radiation oncology, biology, physics.

[8]  M. Anscher,et al.  Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer , 1993 .

[9]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges. , 1992 .

[10]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[11]  S. Wahl.  Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure , 1992, Journal of Clinical Immunology.

[12]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[13]  K. Miyazono,et al.  TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences , 1990, Cell.

[14]  H. Moses,et al.  Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.

[15]  M. Anscher,et al.  Transforming growth factor-beta 1 expression in irradiated liver. , 1990, Radiation research.

[16]  P. Bhatia,et al.  Dose-dependent radiation effect on microvasculature and repair. , 1987, Journal of the National Cancer Institute.

[17]  M. Sporn,et al.  Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Anscher,et al.  Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ , 1995 .

[19]  M. Anscher,et al.  Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis , 1993 .

[20]  P. Canney,et al.  Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? , 1990, The British journal of radiology.

[21]  A B Wolbarst,et al.  Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. , 1987, International journal of radiation oncology, biology, physics.